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Abstract
Most of the studies focused on antimicrobial resistance (AMR) performed in wildlife describe
Escherichia coli as the principal indicator of the selective pressure. In the present study, sev-
eral species of Enterobacterales with a large panel of cephalosporin resistant (CR) genes
have been isolated from wildlife in Catalonia. A total of 307 wild animals were examined to
determine the prevalence of CR enterobacteria, AMR phenotypes and the presence of com-
mon carbapenem and CR genes. The overall prevalence of CR-phenotype was 13% (40/
307): 17.3% in wild mammals (18/104) and 11.5% in wild birds (22/191) (p<0.01). Hedge-
hogs showed the highest prevalence (13.5% of 104) of the mammal specimens, and raptors
the highest in bird specimen (7.3% of 191). Although CR E. coli was the most frequently iso-
lated (45%), other CR- Enterobacterales like Klebsiella pneumoniae (20%), Citrobacter
freundii (15%), Enterobacter cloacae (5%), Proteus mirabilis (5%), Providencia spp (5%)
and Serratia marcescens (2.5%) were also isolated. A high diversity of CR genes was identi-
fied among the isolates, with 50% yielding blaCMY-2, 23% blaSHV-12, 20% blaCMY-1 and
18% blaCTX-M-15. Additionally, resistance to carbapenems associated to OXA-48 gene
was found. Most of the CR isolates, principally K. pneumoniae and C. freundii, were multi-
resistant with co-resistance to fluoroquinolones, tetracycline, sulphonamides and aminogly-
cosides. This study reports high prevalence of Enterobacterales harbouring a variety of CR
genes and OXA-48 mediated-carbapenem resistance, all of them frequently associated to
nosocomial human infections, for the first time in wild mammals and wild birds. Implementa-
tion of control measures to reduce the impact of anthropogenic pressure in the environment
is urgently needed.
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Introduction
In the last decades, the prevalence of opportunistic and antimicrobial resistant (AMR) bacteria
associated with nosocomial infections has increased in hospital settings. The overuse of antibi-
otics in human and veterinary medicine have led to the spread of AMR pathogens, becoming a
global health problem [1].
Extended-spectrum β-lactamases (ESBLs) and AmpC-type β-lactamases (AmpC) are the
most common enzymes that confer resistance to broad-spectrum cephalosporins among
members of the family Enterobacterales. These β-lactamases have extensively diversified in
response to the clinical use of new generation drugs: cephalosporins, carbapenems and mono-
bactams [2]. There are currently two classification systems for beta-lactamase enzymes. The
first one classifies beta-lactamases according to the amino acid sequence [3,4]. The second
classification, described by Bush and Jacoby (2010) is based on the functional activity of the
enzymes. Within this classification, the group 1 contains cephalosporinases encoded in the
chromosome of many Enterobacterales, such as AmpC, CMY, ACT, FOX and MIR. Some vari-
ants of these enzymes have also been detected in plasmids. The group 2 serine beta-lactamase
represents the largest group with a broad spectrum against penicillins, cephalosporins, and
carbapenems. They include the TEM, SHV, CTX, OXA and KPC enzymes. These enzymes are
mostly encoded by genes located in plasmids that can be horizontally transferred to different
bacteria genera [1]. Finally, the group 3 metallo-beta-lactamases (MBLs) are zinc dependent
and include NDM, IMP, VIM and SPM enzymes [5].
Carbapenems are last-line beta-lactam antibiotics with the broadest spectrum of activity.
Nowadays, carbapenems are commonly used in hospital settings for the treatment of life-
threatening infections caused by Enterobacterales resistant to beta-lactamic drugs, including
cephalosporins, monobactams and inhibitors of beta-lactamases. However, the emergence of
resistance to carbapenems mediated by the production of carbapenemases has led to limited
therapeutic options in human health [6]. The OXA-48 variant of carbapenemases is becoming
highly prevalent in human clinical infections [7].
The dissemination of cephalosporin resistance (CR) has been studied widely in Enterobac-
terales from humans and livestock, whereas studies concerning the environment, including
wildlife, are still lacking [2]. In recent years, an important increase of CR Escherichia coli has
been reported in different epidemiological settings such as humans, pets, livestock, retail meat
and the environment [8–13]. The study of wildlife as sentinel of the AMR environmental con-
tamination has recently acquired more consideration worldwide [14]. However, most of the
environmental-wildlife interface studies have been focused on wild birds, as principal AMR
disseminators by their migratory routes, with a limited variety of AMR bacteria species
described. Isolation of CR-carrying bacteria from wild birds has been globally reported in E.
coli [15–20] and less frequently in Klebsiella pneumoniae [21]. All these results confirm the dis-
semination success of ESBL blaSHV-12 and blaCTX-M variants in wild birds worldwide. More
recently, presence of CR E. coli has also been described in wild mammals, but at lower preva-
lence in comparison with wild birds [22].
In the present study, we report for the first time in Spain, the presence of diverse families of
CR-encoding genes in a large variety of Enterobacterales including E. coli, K. pneumoniae,
Citrobacter freundii, Enterobacter cloacae, Serratia marcescens and Proteus mirabilis- in wild
mammals and wild birds. Furthermore, we describe the presence of carbapemenase resistant
E. coli and P. mirabilis associated with the presence of OXA-48 variant in isolates of wildlife
origin. These bacteria are frequently found in recurrent and severe urinary tract infections and
other nosocomial infections in hospitals of Spain [7,23].
ESBL and OXA-48 Enterobacterales in wildlife
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Material and methods
Study population
Wild animals attended at the Wildlife Rehabilitation Centre (WRC) of Torreferrusa (Catalo-
nia, North-East Iberian Peninsula) were analysed between November 2016 and May 2017.
This is a public WRC under the direction of the Catalan Wildlife-Service (“Direccio´ General
de Polı´tiques Ambientals, Departament de Territori i Sostenibilitat of the Generalitat de Cata-
lunya”). Sampling methods and handling protocols of animals were in agreement with the
Catalan Wildlife Service who stipulates the management protocols and Ethical Principles
according to the Spanish legislation [24]. All animals were examined and tested using cloacal
or rectal swabs on arrival at the centre before receiving any pharmacologic or antimicrobial
treatment. The most frequent cause of hospitalization was related to anthropogenic origin due
to direct persecution (gunshot, poisoning, illegal captivity or traps) to involuntary human
induced threats (collisions with vehicles, fences or electric lines and electrocution).
Microbiological analysis
Rectal and cloacal swabs were plated in MacConkey agar supplemented with ceftriaxone
(1mg/L). Single colonies growing on the plate were subculture and identified biochemically
using API (bioMe´rieux, Marcy l’Etoile, France) or VITEK 2 (bioMe´rieux, Spain) systems.
Antimicrobial susceptibility testing
Minimal inhibitory concentration (MIC) was performed using a commercial broth microdilu-
tion method (VetMIC GN-mo, SVA, Sweden) for the following antimicrobials: ampicillin (1
to 128 mg/liter), cefotaxime (0.016 to 2 mg/liter), ceftazidime (0.25 to 16 mg/liter), nalidixic
acid (1 to 128 mg/liter), ciprofloxacin (0.008 to 1 mg/liter), gentamicin (0.12 to 16 mg/liter),
streptomycin (2 to 256 mg/liter), kanamycin (8 to 16 mg/liter), chloramphenicol (2 to 64 mg/
liter), florfenicol (4 to 32 mg/liter), trimethoprim (1 to 128 mg/liter), sulfamethoxazole (8 to
1,024 mg/liter), tetracycline (1 to 128 mg/liter), and colistin (0.5 to 4 mg/liter). The E. coli
ATCC 25922 was used as control strain. Epidemiological cut-off values (ECOFF) selected were
those described by the European Committee on Antimicrobial Susceptibility testing
(EUCAST, https://mic.eucast.org/Eucast2/). For the combinations of species-antimicrobial
with no cut-off values defined by EUCAST, ECOFF values were obtained from the British
Society for Antimicrobial Chemotherapy (BSAC) or the Clinical and Laboratory Standards
Institute (CLSI, 2017).
Molecular characterization of antimicrobial resistance genes
The detection of genes coding for ESBLs -blaCTX-M [25], blaTEM [26], blaSHV [27]-, AmpCs
-blaCMY-1 [28], blaCMY-2 [29], carbapenemases -blaOXA-48, blaVIM, blaIMP, blaNDM and blaKPC
[30]- and colistin-resistance genes mcr1-5 variants [31] was carried out using PCR as previ-
ously described (S1 Table).
Sanger DNA sequencing was done for blaTEM, blaSHV, blaCTX-M, and blaOXA PCR products
at the Genomic and Bioinformatics Service of the Universitat Autònoma de Barcelona (Spain).
Sequences and chromatograms were manually explored to trim bad-quality bases with BioEdit
7.2. Once the assembly of the consensus sequences was done, partial sequences were aligned
using Clustal Omega program, and finally blasted against the public database (National Center
for Biotechnology Information, NCBI). Allelic variants of the ESBL-resistance genes were
determined based on these partial sequences, and AmpC genes were classified according to the
CMY-1 and CMY-2 groups.
ESBL and OXA-48 Enterobacterales in wildlife
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Statistical analysis. Descriptive analysis was performed under 95% confidence, using
SPSS Advanced Models TM 15.0 (SPSS Inc. 233 South Wacker Drive, 11th Floor Chicago, IL
60.606–6412). The Chi-square test or Fisher exact test was used for comparison between pro-
portions when appropriate. Statistically significant results were considered for unadjusted p-
value < 0.05.
Results
The sample size comprised 307 wild animals belonging to 67 different species grouped as birds
(62%), mammals (34%) and reptiles (4%) (Fig 1). Animals came from different regions of Cat-
alonia with a high density of urban areas and pig farming production.
Ceftriaxone resistant isolates were detected in 65 out of the 307 (21%) faecal samples analysed.
Of those, 40 harboured ESBL or AmpC-encoding genes, representing an overall prevalence of
13% (Fig 2). The prevalence of CR-carrying isolates was 17.3% in wild mammals (18/104) and
11.5% in wild birds (22/191). Within the mammal group, hedgehogs showed the largest preva-
lence of resistant isolates in comparison to the total mammal species examined (13.5%, 14/104,
p = 0.022). Precisely, 67% of the Algerian (2/3) and 26% of the European (12/47) samples
Fig 1. Proportion of wildlife analysed in the study according to the zoological category. Animal groups: raptors (different species of birds of prey and owls), wild
birds (principally passerines and seagulls), insectivorous (European and Algerian hedgehogs), carnivores (mainly mustelids), and other mammals (wild boars and
roe deer).
https://doi.org/10.1371/journal.pone.0210686.g001
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harboured CR-genes. Within the bird group, raptors represented the highest prevalence with
7.3% (14/191) of the total bird specimens [23% (14/60) of the raptor species examined] (Fig 2).
CR isolates belonged to several genera within the Enterobacterales order, with E. coli being
detected most frequently (45%). Interestingly, other clinically relevant enterobacteria, includ-
ing K. pneumoniae (20%), C. freundii (15%), E. cloacae (5%), P. mirabilis (5%), Providencia spp
(5%) and S. marcescens (2.5%) were also identified as carriers of CR genes. The proportion of
positive samples for AmpC-encoding genes was 65% (26/40) distributed in 27% blaCMY-1 and
38% blaCMY-2 families. Additionally, 65% (26/40) of the isolates exhibited ESBL genes with
blaSHV-12 (9/40, 22.5%) and blaCTX-M-15 (6/40, 15%) representing 35% and 23% of the total
ESBL respectively. Isolates from 12 animals presented the combination of both, ESBL and
Fig 2. Prevalence of cephalosporin resistant (CR) bacteria in the different wildlife categories.
https://doi.org/10.1371/journal.pone.0210686.g002
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AmpC genes. Finally, mammals and raptors shared the largest part of the detected ESBL types,
and other minority gene variants, such as blaCTX-M-3 and blaSHV-11 or blaSHV-167 were only
detected in mammals or raptors, respectively (Fig 3).
A high genetic diversity of CR encoding genes was observed in all Enterobacterales, with
40% (16/40) of the isolates harbouring 2 to 5 different resistance genes in the same isolate
(Table 1). Furthermore, the carbapenemase-encoding gene OXA-48 was detected in E. coli
and P. mirabilis isolated from European hedgehog and Barn owl, respectively (Table 1). Other
carbapenemase-encoding genes tested were not found.
Most of the ESBL/AmpC Enterobacterales isolated (92%), with the exception of E. cloacae,
were multiresistant with a common resistance phenotype comprising β-lactams-quinolones-
tetracycline-sulfamethoxazole/trimethoprim (Table 1). K. pneumoniae and C. freundii isolates
both presented a multi-drug resistance profile including the resistance to aminoglycosides
(Table 2). Moreover, 90% of the K. pneumoniae isolates were resistant to ciprofloxacin and
Fig 3. Venn diagram showing the distribution of AMR genes in the different animal groups encountered in this study.
https://doi.org/10.1371/journal.pone.0210686.g003
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Table 1. Prevalence and antimicrobial resistance genotypes and phenotypes of beta-lactamase producing Enterobacterales detected in wildlife.
Scientific name (common name) Total
sample
AMR
genes
Bacterial spp Drug-resistance genes Resistance phenotype to
non-Beta-lactams
Mammals (N = 104) N n Prev
Aetechinus algirus (Algerian
hedgehog)
3 2 67% Escherichia coli CMY-2 CIP, NAL, KAN, TMP
Klebsiella oxytoca CTX-M-3 GEN, ST, FF, CF, TET, COL, TMP
Erinaceus europeus (European
hedgehog)
47 12 26% Escherichia coli CMY-2 nd
Escherichia coli CMY-2 KAN
Escherichia coli CMY-2 nd
Escherichia coli SHV-12 STR
Escherichia coli SHV-11,OXA-48 CIP, NAL, KAN, TET, SUL, TMP
Klebsiella
pneumoniae
CMY-1,CMY-2, SHV-1,TEM-1,
CTX-M-15
CIP, GEN, ST, KAN, TET, SUL, TMP
Klebsiella
pneumoniae
SHV-11, TEM-1 CIP, NAL, GEN, STP, KAN, TET, SUL,
TMP
Klebsiella
pneumoniae
SHV-28 CIP, NAL, GEN, STR, KAN, TET, COL,
SUL, TMP
Klebsiella
pneumoniae
SHV-12 CIP, NAL, KAN, TET, SUL, TMP
Citrobacter freundii CMY-2, TEM-1 CIP, NAL, KAN, TET, TMP
Citrobacter freundii CMY-2, SHV-12 CIP, NAL, STR, KAN, TET, COL, SUL,
TMP
Citrobacter freundii CMY-2 CIP, NAL
Capreolus capreolus (European roe
deer)
2 1 na Enterobacter cloacae CMY-2 SUL
Martes foina (Beech marten) 2 1 na Citrobacter freundii CMY-2, SHV-12 CIP, NAL, GEN, TET, SUL, TMP
Meles meles (European badger) 1 1 na Escherichia coli SHV-12 CIP, NAL, CHL, SUL, TMP
Mustela vison (American mink) 13 1 8% Enterobacter cloacae CMY-2 SUL
PREVALENCE IN MAMMALS 104 18 17.3%
Raptors (n = 108) N n Prev
Accipiter gentilis (northern
goshawk)
13 3 23% Escherichia coli TEM-1 COL
Escherichia coli CMY-2 CIP, NAL
Proteus mirabilis CMY-1, CMY-2, SHV-28, TEM-1 CIP, NAL, GEN, STR, KAN, TET, SUL,
TMP
Accipiter nisus (Eurasian
sparrowhawk)
8 3 38% Escherichia coli CMY-1, SHV-1, TEM-1, CTX-M-
15
CIP, NAL, KAN, TET, SUL, TMP
Escherichia coli TEM-1 CIP, TET, TMP
Serratia marcensis CMY-1, CTX-M-15 CIP, TET, COL, SUL, TMP
Bubo bubo (Eurasian eagle-owl) 1 1 na Escherichia coli CMY-1, SHV-167 nd
Buteo buteo (Common buzzard) 17 2 12% Escherichia coli SHV-12 ST, CHL, TET, SUL, TMP
Providencia
alcalifaciens
SHV-12 CIP, NAL,GEN,ST,KAN, FF,CHL, TET,
SUL, TMP
Strix aluco (Tawny owl) 18 3 17% Klebsiella
pneumoniae
CMY-2, SHV-28 STR, SUL, TMP
Escherichia coli CMY-2, SHV-1 nd
Klebsiella
pneumoniae
SHV-12, CTX-M15 CIP
Tyto alba (Barn owl) 3 2 67% Escherichia coli CMY-2 CIP, NAL, STR, TET
Proteus mirabilis SHV-12,TEM-1, OXA-48 CIP, NAL, STR, KAN, CF, TET, COL,
SUL,TMP
Other birds (n = 83) N n Prev
(Continued)
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sulphametoxazole, 70% to kanamycin, 55% to streptomycin, and 10% to florfenicol. Addition-
ally, 83% of the tested C. freundii isolates exhibited resistance to trimethoprim and nalidixic
acid and 67% to tetracycline (Table 2). Although none of the mcr- genes were detected in this
study, the colistin resistant phenotype was observed in Klebsiella spp isolated from a European
greenfinch and Algerian hedgehog, and in a Providencia spp isolated from a common buzzard.
Discussion
This study identifies for the first time a high percentage of wild mammals and wild birds as
carriers of potential nosocomial Enterobacterales harbouring diverse ESBL, CMY and OXA-48
genes. Moreover, most of the isolates principally K. pneumoniae and C. freundii, presented a
high prevalence of resistance also to fluoroquinolones.
In general, E. coli is the most reported ESBL/pAmpC-producing enterobacteria worldwide,
with increasing frequency from animals, food, environmental sources and humans. In recent
years, CR- E. coli transmission has been reported in different hosts, demonstrating a close
human-animal ESBL/pAmpC gene similarity between livestock (broilers and pigs) and per-
sonnel working at the farms [13]. Additionally, similar CR genes have been reported between
isolates from the community and those from human clinical settings, sewage water and wild
birds [13].
Although ESBL transmission has been studied extensively in Enterobacterales from humans
and livestock, data on antimicrobial resistance in the environment is still limited [2]. Moreover,
most of the studies related to ESBL-carrying bacteria in wildlife are focused on the wild bird
population and mainly restricted to E. coli species [32]. Several studies conducted in E. coli from
avian species have identified blaCTX-M-1, blaCTX-M-14, blaCTX-M-15 and blaSHV-12 as the predomi-
nant ESBL types circulating in Spain [15, 33–36], Portugal [37], Tunisia [20], The Netherlands
[38], Poland [39] and the Czech Republic [40]. Contrarily, in the present study, blaCTX-M-1 and
blaCTX-M-14 were not detected in our avian species, but blaSHV-12 and blaCTX-M-15 were the most
Table 1. (Continued)
Scientific name (common name) Total
sample
AMR
genes
Bacterial spp Drug-resistance genes Resistance phenotype to
non-Beta-lactams
Carduelis carduelis (European
goldfinch)
12 1 8% Citrobacter freundii CMY-2 CIP, NAL, GEN, STR, KAN, CHL, TET,
SUL, TMP
Carduelis choris (European
Greenfinch)
2 1 na Klebsiella
pneumoniae
CMY-1 CIP, NAL, KAN, FF, CHL, SUL
Larus michahellis (Yellow-legged
gull)
7 1 14% Escherichia coli CTX-M-15 CIP, NAL, GEN, KAN, TET, SUL, TMP
Serinus serinus (European serin) 6 1 17% Klebsiella
pneumoniae
CMY-1, SHV-28 CIP, NAL, STR, KAN, TET, SUL, TMP
Streptopelia decaocto (Eur. collared
dove)
1 1 na Citrobacter freundii CMY-2 FF, TMP
Sylvia melanocephala (Sardinian
warbler)
6 2 33% Escherichia coli CMY-2 CIP, NAL
Providencia spp CTX-M-15, CMY-1 CIP, NAL, GEN, STR, KAN, CHL, TET,
SUL, TMP
Turdus merula (Common
blackbird)
8 1 13% Escherichia coli CMY-2 CIP, NAL, KAN, TMP
PREVALENCE IN BIRDS 191 22 11.5%
CIP, Ciprofloxacin; NAL, Nalidixic acid; GEN, Gentamicin; STR, Streptomycin; KAN, Kanamycin; FF, Florfenicol; CHL, Chloramphenicol; TET, Tetracycline; COL,
Colistin; SUL, Sulphametoxazole; TMP, Trimethoprim. nd, not detected.
https://doi.org/10.1371/journal.pone.0210686.t001
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Table 2. Minimal inhibitory concentration of E. coli, K. pneumoniae and C. freundii isolates of wildlife origin. Dilution ranges for each antimicrobial are those con-
tained within the white area. Vertical lines indicate epidemiological cut off values (ECOFF) or clinical breakpoints in those cases where ECOFF values have not been
described.
E. coli (n = 18)
MIC [μg/mL]: 0.12 0.25 0.5 1 >2 4 8 16 >16 32 64 >128 256 >512 R (%)
Ampicilin 3 15 100
Cefotaxime 1 1 1 2 12 1 89
Ceftazidime 2 1 1 7 7 100
Ciprofloxacin 6 2 2 8 67
Nalidixic acid 2 3 4 9 50
Gentamicin 9 8 1 5.5
Streptomycin 7 3 5 2 1 17
Kanamycin 12 2 4 33
Florfenicol 4 12 2 0
Chloramphenicol 2 8 5 1 2 11
Tetracycline 6 6 1 2 3 33
Colistin 17 1 5.5
Sulphametoxazole 2 9 1 1 5 28
Trimethoprim 1 7 2 8 44
K. pneumoniae (n = 9)
MIC [μg/mL]: 0.12 0.25 0.5 1 >2 4 8 16 >16 32 64 >128 256 >512 R (%)
Ampicilina 1 8 100
Cefotaxime 9 100
Ceftazidime 3 6 100
Ciprofloxacin 1 8 100
Nalidixic acida 1 2 1 5 88
Gentamicin 1 5 3 33
Streptomycin 2 2 2 3 ND
Kanamycina 2 7 78
Florfenicol 1 7 1 ND
Chloramphenicola 1 5 1 1 1 22
Tetracycline 1 1 2 1 4 56
Colistin 8 1 11
Sulphametoxazoleb 1 8 89
Trimethoprimb 1 2 6 67
C. freundii (n = 6)
MIC [μg/mL]: 0.12 0.25 0.5 1 >2 4 8 16 >16 32 64 >128 256 >512 R (%)
Ampicilina 1 5 100
Cefotaxime 1 5 83
Ceftazidime 1 1 4 83
Ciprofloxacinb 1 5 0
Nalidixic acida 1 5 83
Gentamicin 1 1 2 2 33
Streptomycin 1 1 2 1 1 ND
Kanamycinb 3 3 50
Florfenicol 3 2 1 ND
Chloramphenicola 1 2 1 1 1 33
Tetracycline 2 1 2 1 67
Colistina 4 1 1 33
Sulphametoxazoleb 2 1 3 50
(Continued)
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frequent ESBL types identified not only in E. coli but also in K. pneumoniae and C. freundii iso-
lates. K. pneumoniae has been described in low prevalence (average 1.5%) in wild gulls from dif-
ferent European countries [41–43], including wild migratory birds from Spain, which exhibited
blaCTX-M-15 ESBL-producing K. pneumoniae [36]. Interestingly, both blaCTX-M-15 and blaSHV-12
are also currently the most predominant genes in human clinical specimens from community
and health care-associated infections in Spain [44,45]. Thus, the human community could
potentially be a source of ESBL environmental contamination, through water contaminated
with human sewage from urban areas and hospital settings.
In this study, blaCMY-1 group was principally detected in E. coli, K. pneumoniae, Proteus and
Providencia spp from avian wildlife, like hawks, owls and small forest birds. Although this is an
unusual variant in Spain, the presence in the present study might be explained by those species
feeding habits. Raptors are predators occupying the top of the food chain; therefore, they can
acquire AMR from a wide variety of preys (mammals, birds, reptiles or scavenging livestock).
Moreover, some of these raptors are migratory species, being exposed to different environ-
mental habitats in their migratory movements. In consequence, the role of migratory raptors
as disseminators of these AMR traits is a serious concern to be further investigated.
Regarding blaCMY-2, it is the most common CMY type reported worldwide [46]. In this
study, blaCMY-2 group was highly detected in E. coli and K. pneumoniae from hedgehogs and
wild birds. Plasmid mediated genes can spread easily to other organisms. C. freundii, Entero-
bacter and Serratia spp in this study presented genes of the CMY-2 family. Since these types of
AmpC genes are chromosomally encoded in some of these bacteria species, we cannot con-
clude the plasmidic nature of such enzymes. However, for epidemiological studies, it is impor-
tant to report this type of resistance since these Enterobacterales can be involved in severe
nosocomial infections and they all presented a MDR profile, except for E. cloacae.
Surprisingly, European hedgehogs represented an important reservoir of ESBL/AmpC-pro-
ducing E. coli and other Enterobacterales, especially for blaCMY-2 (67%) and blaSHV-12 (25%) in
this study. Our results are in agreement with previous studies conducted in Spain reporting
low to moderate (1.3%-10%) prevalence of blaCMY-2 and blaSHV-12 E. coli variants in hedge-
hogs, deer and minks [22,47]. It is important to highlight that hedgehogs are in close contact
with humans (home range including gardens), but also with livestock in the countryside,
which could explain their acquisition of these AMR types.
Plasmid-mediated colistin resistance by mcr-1 has been reported worldwide in Enterobacter-
ales isolated from humans, livestock, companion animals, food and wildlife [48]. Colistin has
been used in veterinary medicine during the last decades for the treatment of gastrointestinal
infections in livestock, principally in pigs and poultry [49]. Consequently, livestock is considered
the main reservoir of mcr-1 selection and dissemination worldwide. Recent works disclosed the
relationship among mcr-1-harbouring E. coli isolates recovered from the environment, pig pro-
duction and human clinical isolates, demonstrating the rapidly evolving epidemiology of plas-
mid-mediated colistin-resistant E. coli strains worldwide and the importance of the One Health
Table 2. (Continued)
Trimethoprimb 1 5 83
EUCAST (ECOFF values WT): AMP�8, CTX�0.25, CAZ�0.5 (�1 C.freundii), CIP�0.064 (�0.125 K.pneumoniae), NAL�16, GEN�2, STR� 16, KAN�8, FFL
�16, CHL�16, TET�8, COL�2, SMX�64, TMP�2 (�8 K. pneumoniae and C. freundii).
aBSAC and
bCLSI clinical break points: CIP�1 Enterobacteriaceae, SMX Susceptible �256 K. pneumoniae and C. freundii; TMP�8 K. pneumoniae and C. freundii. ND, not
determined due to lack of ECOFF or clinical breakpoint values available. CLSI: Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI
supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
https://doi.org/10.1371/journal.pone.0210686.t002
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approach [50,51]. In our study, some Klebsiella and Providencia spp isolates were phenotypically
resistant to colistin, but no mcr-associated genes were detected in any of the examined isolates.
Information about carbapenem-resistant Enterobacterales is very scarce in wildlife and has
only been reported in avian species [36,52]. In this study, we report the presence of blaOXA-48
in E. coli and P. mirabilis isolates from a European hedgehog and a Barn owl, respectively. The
presence of blaOXA-48 in wild mammals and birds in Catalonia is highly indicative of the wide
environmental pollution of this variant, commonly reported in hospitals in Spain [53].
To our knowledge, there are no reports in wildlife, especially in wild mammals, describing
the presence of ESBL genes in such a variety of Enterobacterales, like Klebsiella spp, Citrobacter
spp, Serratia spp, or Enterobacter spp in Spain. C. freundii, is considered an opportunistic
pathogen, associated with nosocomial infections, especially in patients who have been hospital-
ized for a prolonged period of time. In the last years, this bacterium has been classified as an
emerging health problem associated to urinary tract infections commonly diagnosed in health-
care settings [54]. E. cloacae has been reported as important opportunistic and multi-resistant
pathogen involved in outbreaks of hospital-acquired infections worldwide [55,56], including
Spain [57]. ESBL- S. marcescens has also been classified as one of the top ten priority pathogens
causing infections in intensive care units [58].
The high prevalence of CR Enterobacterales encountered in this study is really concerning,
since wildlife is not directly exposed to any antimicrobial agent. Therefore, faecal contamina-
tion of water or soil with MDR bacteria and/or antimicrobial residues can lead to a selection
pressure. Wastewaters from urban areas and hospitals have been identified as one of the major
sources of AMR environmental contamination [2]. High prevalence of blaSHV-12 but also bla-
TEM-1 and blaCTX-M-1 alleles have been reported in aquatic environments (urban waters, natu-
ral or artificial water reservoirs, seawater or drinking water) in several countries worldwide,
likely due to their relatively easy transmission to surface water through waste water treatment
plant discharges [2,59]. In our study, wildlife in close contact with urban and farming areas of
Catalonia carried a large variety of zoonotic/nosocomial bacteria genetically resistant to β-lac-
tams-quinolones-tetracycline-sulfamethoxazole/trimethoprim-aminoglycosides with similar
resistant genes to those found in livestock and clinical settings. However, further studies are
needed to assess clonal relatedness among different cephalosporin and carbapenem resistant
enterobacteria at the human-animal-environment interface.
Conclusions
This study describes for the first time a high prevalence of Enterobacterales harbouring a large
variety of ESBL in addition to carbapenem resistant OXA-48 genes in wild mammals, remark-
ably in hedgehogs, and wild birds in Catalonia (northeast Spain). AmpC CMY-2 group and
the ESBL genes blaSHV-12 and blaCTX-M-15 were the most frequent types identified in E. coli, K.
pneumoniae and C. freundii isolates. These results support the concept that wildlife is a good
sentinel of AMR environmental contamination and underline the importance of the One
Health approach since wildlife can contribute indirectly to the dissemination of resistance
genes into other natural environments.
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